SR1062 Summary

• Declares May 3-9, 2020 as "Tardive Dyskinesia Awareness Week" in Illinois.

• Recognizes that Tardive Dyskinesia is a movement disorder affecting over 500,000 Americans, with one in four patients on long-term antipsychotic medication at risk of developing the condition.

• Notes that Tardive Dyskinesia can develop months, years, or decades after starting dopamine receptor blocking agent medications and is often permanent once it develops.

• Acknowledges that two new FDA-approved treatments for Tardive Dyskinesia have recently been developed, and that regular screening by healthcare providers is recommended.

• Urges Illinois citizens and the public to become better informed about Tardive Dyskinesia and its impact on patients and caregivers.